all-trans-Retinol [68-26-8]
R1876
Estimated Purity≥95%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product Nameall-trans-Retinol [68-26-8]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥95%
- FormatSoluble in alcohol, methanol, chloroform, ether, fats or oils.
- Scientific DescriptionDiterpene component of vitamin A, differentiation inducer; RAR and RXR agonist.; Alphasterol, Retinol, Avitol, Vitamin A
- Storage Instruction-20°C
- UNSPSC12352200
References
- Friedman MD, Jeevan DS, Tobias M, et al. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Oncol Rep. 2013 Oct;30(4):1645-50. PMID: 23877261. Farhangi MA, Keshavarz SA, Eshraghian M, et al. Vitamin a supplementation and serum Th1- and th2-associated cytokine response in women. J Am Coll Nutr. 2013 Aug;32(4):280-5. PMID: 24024773. Sharma RB, Wang Q, Khillan JS. Amplification of tumor inducing putative cancer stem cells (CSCs) by vitamin A/retinol from mammary tumors. Biochem Biophys Res Commun. 2013 Jul 12;436(4):625-31. PMID: 23764401. Zhan XX, Liu Y, Yang JF, et al. All-trans-retinoic acid ameliorates experimental allergic encephalomyelitis by affecting dendritic cell and monocyte development. Immunology. 2013 Apr;138(4):333-45. PMID: 23181351. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell. 2008 Sep 19;134(6):921-31. PMID: 18805086.